KEZAR LIFE SCIENCES INC - PALIZADE PHASE 2B CLINICAL TRIAL IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS (LN) WILL BE DISCONTINUED

Reuters · 10/17 12:30

Please log in to view news